Shire Seeks Toss Of Fortis Bid For $425M Drug Study Payout
By Jeff Montgomery ( August 29, 2016, 5:19 PM EDT) -- Shire US Holdings Inc. asked Delaware's Chancery Court late Friday to reject a breach of contract lawsuit amendment that would boost to $425 million the amount shareholders of an acquired company claim they are due after regulatory approval of a new dry-eye drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.